08355362falsePharmaceutical consultancy2022-02-012023-01-31http://www.companieshouse.gov.uk/2022-01-31http://www.companieshouse.gov.uk/cd:Director12022-02-012023-01-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2022-02-012023-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2023-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2022-01-31http://www.companieshouse.gov.uk/2022-02-012023-01-31http://www.companieshouse.gov.uk/2022-01-31http://www.companieshouse.gov.uk/2023-01-31http://www.companieshouse.gov.uk/cd:FullAccounts2022-02-012023-01-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2022-02-012023-01-31http://www.companieshouse.gov.uk/cd:Micro-entities2022-02-012023-01-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 08355362

Cassini Medical Ltd

ACCOUNTS
FOR THE YEAR ENDED 31/01/2023

Prepared By:
Arcus
Taxation Accountants
2B Gaol Street
Oakham
Rutland
LE15 6AQ

Cassini Medical Ltd

Registered Number: 08355362
BALANCE SHEET AT 31/01/2023
20232022
££
Fixed assets1,2901,882
Current assets55,05255,118
Creditors: amounts falling due within one year(36,171)(1,335)
Net Current Assets18,88153,783
Total assets less current liabilities20,17155,665
Net Assets20,17155,665
Capital and reserves20,17155,665
Average Number of Employees
During the year the average number of employees was 1.
Company information
Private company limited by shares registered in EW - England and Wales, registered number 08355362. Registered office 1 Sunnyfield, Oakham, Rutland, LE15 6NE
For the year ending 31/01/2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the micro-entities regime.
These accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board on 09/10/2023 and signed on their behalf by
.............................
Andrew Dean
Director